Your browser doesn't support javascript.
loading
Erythromycin associated hearing loss in a patient with prior cis-platinum induced ototoxicity.
Wallach, P M; Love, S R; Fiorica, J V; Hoffman, M S; Flannery, M T.
Affiliation
  • Wallach PM; Department of Internal Medicine, University of South Florida College of Medicine, Tampa.
J Fla Med Assoc ; 79(12): 821-2, 1992 Dec.
Article in En | MEDLINE | ID: mdl-1474367
ABSTRACT
A case is reported of reversible sensorineural hearing loss associated with intravenous erythromycin treatment. Cis-platinum induced high frequency hearing loss developed nine months previously during treatment for stage IV papillary cystadenocarcinoma. Renal and hepatic function were normal; however, serum erythromycin levels were elevated. Clinical recovery promptly followed discontinuation of erythromycin.
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Erythromycin / Cisplatin / Hearing Loss, High-Frequency / Hearing Loss, Sensorineural Type of study: Risk_factors_studies Limits: Female / Humans / Middle aged Language: En Journal: J Fla Med Assoc Year: 1992 Document type: Article
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Erythromycin / Cisplatin / Hearing Loss, High-Frequency / Hearing Loss, Sensorineural Type of study: Risk_factors_studies Limits: Female / Humans / Middle aged Language: En Journal: J Fla Med Assoc Year: 1992 Document type: Article